CM Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Hold
12,251
0.07% 102
2025
Q4
$305K Buy
+12,251
New +$309K 0.07% 112
2024
Q2
Sell
-11,518
Closed -$320K 148
2024
Q1
$320K Buy
+11,518
New +$320K 0.09% 128
2023
Q3
Sell
-5,568
Closed -$203K 146
2023
Q2
$203K Sell
5,568
-23,156
-81% -$901K 0.07% 152
2023
Q1
$1.11M Buy
+28,724
New +$1.24M 0.21% 134

Other funds holding PFE

CM Wealth Advisors's PFE Position: Q1 2026 in Review

CM Wealth Advisors held its Pfizer (PFE) position steady in Q1 2026 at 12,251 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #102.

CM Wealth Advisors first reported a position in PFE in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.11M in Q1 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CM Wealth Advisors held 12,251 shares of Pfizer worth $344K as of Q1 2026.
  • CM Wealth Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.07% of CM Wealth Advisors's portfolio in Q1 2026, its #102 holding.
  • CM Wealth Advisors first reported a position in Pfizer in Q1 2023 and has held it in 5 quarters since.
  • CM Wealth Advisors's Pfizer position peaked at $1.11M in Q1 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CM Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.